---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-001524"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T18:28:23.114274+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Collegium Pharma reports record Q4/FY2023 revenue; GAAP net income of $31.9M Q4, $48.2M FY

## Summary
- Record Q4 revenue $149.7M (+16% YoY); FY revenue $566.8M (+22% YoY).
- GAAP net income $31.9M Q4 ($0.82 diluted) vs loss of $7.2M in Q4 2022; FY net income $48.2M.
- Record adjusted EBITDA $104.2M Q4, $367.0M FY (+38% YoY each).
- Repurchased $75M shares in 2023; new $150M buyback authorized Jan 2024.
- FY 2024 guidance: product revenue $580–595M, adjusted EBITDA $380–395M.

## SEC filing metadata
- accession: 0001558370-24-001524
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000155837024001524/0001558370-24-001524-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000155837024001524/coll-20240222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-001524
- JSON: https://secwatch.observer/filing/0001558370-24-001524.json
- Plain text: https://secwatch.observer/filing/0001558370-24-001524.txt

## Key facts
- Earnings Releases
  COLLEGIUM PHARMACEUTICAL, INC reported the quarterly period and fiscal year ended December 31, 2023 results: revenue $149.7 Million and $566.8 Million, net income $31.9 Million and $48.2 Million, EPS $0.99 GAAP earnings per share (basic) and $0.82 GAAP earnings per share (diluted); $1.43 GAAP earnings per share (basic). Guidance reaffirmed.
  - Period: the quarterly period and fiscal year ended December 31, 2023
  - Revenue: $149.7 Million and $566.8 Million
  - Net income: $31.9 Million and $48.2 Million
  - EPS: $0.99 GAAP earnings per share (basic) and $0.82 GAAP earnings per share (diluted); $1.43 GAAP earnings per share (basic)
  - Guidance: reaffirmed
  - Result: reported results
  source text: 8-K. ​ --- EX-99.1 (EX-99.1) --- ​ Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results ​ – Generated Record Quarterly and Full-Year Net Revenue of $149.7 Million and $566.8 Million – ​ – Achieved Quarterly and Full-Year GAAP Net Income of $31.9 Million and $48.2 Million – ​ – Delivered Record Quarterly and Full-Year Adjusted EBITDA of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000155837024001524/0001558370-24-001524-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.